OptimizeRx Corp Income Statement
OPRX|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
OptimizeRx Corp reported $92M in revenue and $20M in net loss for FY2025. Revenue has grown at a 66.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92.1M | $71.5M | $62.5M | $61.3M | $43.3M | $24.6M | $21.2M | $12.1M | $7.8M | $7.2M | $6.5M | $3.0M | $2.0M | $1.1M | $71.1K |
| Cost of Revenue | $32.7M | $28.6M | $23.5M | $25.7M | $19.2M | $9.2M | $9.0M | - | - | - | - | - | - | - | - |
| Gross Profit | $59.4M | $42.9M | $39.0M | $35.6M | $24.1M | $15.4M | $12.2M | $6.0M | $4.3M | $3.6M | $3.3M | $2.8M | $1.9M | - | - |
| SG&A Expense | - | - | - | $27.7M | - | - | - | - | - | - | - | - | $269.4K | $445.9K | - |
| R&D Expense | $0 | - | - | - | - | $1.6M | $0 | - | - | - | - | - | - | - | - |
| Operating Income | -$13.7M | -$26.4M | -$12.3M | $361.1K | -$2.1M | -$3.7M | $180.1K | -$2.1M | -$1.6M | -$597.4K | -$1.0M | -$267.5K | -$454.9K | $13.5M | -$1.8M |
| Interest Expense | - | - | $1.5M | - | - | - | - | - | - | - | $0 | $0 | - | $958.6K | -$106.6K |
| Income Tax | $725.0K | -$7.6M | -$7.6M | - | - | -$898.0K | -$898.0K | - | - | - | $0 | $0 | - | - | - |
| Net Income | -$20.1M | -$17.6M | -$11.4M | $378.1K | -$2.2M | -$3.1M | $226.3K | -$2.1M | -$1.5M | -$595.1K | -$1.0M | -$659.9K | -$454.6K | -$2.1M | -$2.0M |
| EPS (Basic) | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | - | -$0.02 | -$0.04 | - | - | - | - |
| EPS (Diluted) | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | -$0.05 | - | - | -$0.02 | - | - | - |
| Shares Outstanding | 18.5M | 17.1M | 17.8M | 17.9M | 15.2M | 14.6M | 12.0M | 9.8M | 29.7M | 29.0M | 22.9M | 14.8M | 17.2M | - | - |
| Gross Margin | 64.5% | 60.0% | 62.4% | 58.1% | 55.6% | 62.8% | 57.6% | 49.1% | 56.0% | 49.8% | 50.5% | 94.0% | 94.2% | - | - |
| Operating Margin | -14.9% | -36.9% | -19.7% | 0.6% | -4.9% | -15.0% | 0.9% | -17.6% | -20.4% | -8.3% | -15.8% | -8.9% | -22.9% | 1212.7% | -2598.0% |
| Profit Margin | -21.8% | -24.6% | -18.3% | 0.6% | -5.1% | -12.8% | 1.1% | -17.3% | -19.9% | -8.2% | -15.8% | -22.0% | -22.9% | -190.8% | -2827.0% |